Ceria Nanoparticles Meet Hepatic Ischemia‐Reperfusion Injury: The Perfect Imperfection
- 16 August 2019
- journal article
- research article
- Published by Wiley in Advanced Materials
- Vol. 31 (40) , e1902956
Abstract
The mononuclear phagocyte system (MPS, e.g., liver, spleen) is often treated as a “blackbox” by nanoresearchers in translating nanomedicines. Often, most of the injected nanomaterials are sequestered by the MPS, preventing their delivery to the desired disease areas. Here, this imperfection is exploited by applying nano‐antioxidants with preferential liver uptake to directly prevent hepatic ischemia‐reperfusion injury (IRI), which is a reactive oxygen species (ROS)‐related disease. Ceria nanoparticles (NPs) are selected as a representative nano‐antioxidant and the detailed mechanism of preventing IRI is investigated. It is found that ceria NPs effectively alleviate the clinical symptoms of hepatic IRI by scavenging ROS, inhibiting activation of Kupffer cells and monocyte/macrophage cells. The released pro‐inflammatory cytokines are then significantly reduced and the recruitment and infiltration of neutrophils are minimized, which suppress subsequent inflammatory reaction involved in the liver. The protective effect of nano‐antioxidants against hepatic IRI in living animals and the revealed mechanism herein suggests their future use for the treatment of hepatic IRI in the clinic.Keywords
Funding Information
- University of Wisconsin-Madison
- National Science Foundation (P30CA014520)
- National Natural Science Foundation of China (81471712, 81671747)
- Youth Innovation Promotion Association of the Chinese Academy of Sciences (20190218)
This publication has 50 references indexed in Scilit:
- The Reactive Oxygen Species–Mitophagy Signaling Pathway Regulates Liver Endothelial Cell Survival During Ischemia/Reperfusion InjuryLiver Transplantation, 2018
- Reactive Oxygen and Nitrogen Species and Liver Ischemia-Reperfusion Injury: An Overview2018
- Lipid metabolic reprogramming in hepatic ischemia–reperfusion injuryNature Medicine, 2018
- Hepatic ischemia and reperfusion injury: Effects on the liver sinusoidal milieuJournal of Hepatology, 2013
- Ischemia and reperfusion—from mechanism to translationNature Medicine, 2011
- Delivery of antioxidative enzyme genes protects against ischemia/reperfusion–induced liver injury in miceLiver Transplantation, 2006
- Protective strategies against ischemic injury of the liverGastroenterology, 2003
- Hepatic ischemia/reperfusion injury—a fresh lookExperimental and Molecular Pathology, 2003
- Reactive oxygen and ischemia/reperfusion injury of the liverChemico-Biological Interactions, 1991
- THE INFLUENCE OF PRESERVATION INJURY ON REJECTION IN THE HEPATIC TRANSPLANT RECIPIENTTransplantation, 1990